Lymphatic Diseases D008206

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases

Description

Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.   MeSH

Hierarchy View

Subtype Terms (14)

Histiocytosis
20 drugs (14 approved, 6 experimental)

Lymphadenitis
 

Lymphadenopathy
16 drugs (14 approved, 2 experimental)

Lymphangiectasis
 

Lymphangitis
 

Lymphatic Abnormalities
 

Lymphedema
36 drugs (17 approved, 19 experimental)

Lymphocele
2 approved drugs

Lymphoproliferative Disorders
112 drugs (74 approved, 38 experimental)

Mucocutaneous Lymph Node Syndrome
14 approved drugs

Pseudolymphoma
 

Splenic Diseases
 

Thymus Hyperplasia
 

Thymus Neoplasms
15 drugs (9 approved, 6 experimental)


Phase 4 Indicated Drugs (2)

Phase 3 Indicated Drugs (2)

Other Experimental Indicated Drugs (3)


Organization Involved with Other Experimental Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.